Search Within

Department of Medicine

Formats
  1. Journal Article (19621)
  2. Meeting Abstract (16084)
  3. Review (1159)
  4. Book Section (934)
  5. Editorial (612)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (237)
  10. Miscellaneous (91)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22369)
  2. Hematologic Malignancies, Division of (13308)
  3. Center for Hematologic Malignancies (11082)
  4. GSK Faculty (10659)
  5. Survivorship Research (9353)
  6. Division of Subspecialty Medicine (7561)

More Groups

People
  1. Robert Motzer (1251)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1161)
  2. 2024 (2293)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1411)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (904)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2898)
  5. Oxford University Press (2304)
  6. Nature Publishing Group (2122)

More Publishers

Results (39714)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of survival in patients with MALT lymphoma: A retrospective, case-control study
    Review

    Qi, S.; Liu, X.; Noy, A.; Lee, J.; Teckie, S.; Hajj, C.; Joffe, E.; Imber, B. S.; Yahalom, J.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Gilbert, L. J.; Hanley, D. M.; Flynn, J. R.; Devlin, S. M.; Nguyen, L. K.; Ruiz, J. D.; Shah, G. L.; Sauter, C. S.; Chung, D. J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Dasatinib/prednisone induction followed by blinatumomab/ dasatinib in Ph(+) acute lymphoblastic leukemia
    Journal Article

    Advani, A. S.; Moseley, A.; O’Dwyer, K. M.; Wood, B. L.; Park, J.; Wieduwilt, M.; Jeyakumar, D.; Yaghmour, G.; Atallah, E. L.; Gerds, A. T.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
    Journal Article

    Younes, A.; Burke, J. M.; Cheson, B. D.; Diefenbach, C. S.; Ferrari, S.; Hahn, U. H.; Hawkes, E. A.; Khan, C.; Lossos, I. S.; Musuraca, G.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • DNA polymerase θ protects leukemia cells from metabolically induced DNA damage
    Journal Article

    Vekariya, U.; Toma, M.; Nieborowska-Skorska, M.; Le, B. V.; Caron, M. C.; Kukuyan, A. M.; Sullivan-Reed, K.; Podszywalow-Bartnicka, P.; Chitrala, K. N.; Atkins, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Phase 3 MAGNITUDE study: Results from second interim analysis of niraparib with abiraterone acetate and prednisone as first-line therapy in patients with metastatic castration-resistant prostate cancer with and without HRR gene alteration
    Meeting Abstract

    Rathkopf, D. E.; Small, E.; Guckert, M.; Chi, K. N.
    Oncology Nursing Forum (2023)

    Fulltext@MSK | Save
  • Patients receiving short run-in treatment (≤2 months) with abiraterone acetate and prednisone (AAP) showed similar benefit from niraparib and AAP in the phase 3 MAGNITUDE study with metastatic castration-resistant prostate cancer and HRR gene alterations
    Meeting Abstract

    Smith, M.; Efstathiou, E.; Rathkopf, D. E.; Guckert, M.; Chi, K. N.
    Oncology Nursing Forum (2023)

    Fulltext@MSK | Save
  • Communicating with patients with advanced cancer
    Book Section

    Parker, P. A.; Epstein, A. S.; Rosa, W. E.; Banerjee, S. C.
    In Chochinov, H.; Breitbart, W. (Eds.) Handbook of Psychiatry in Palliative Medicine: Psychosocial Care of the Terminally Ill. 3rd ed (2023)

    Fulltext@MSK | Save
  • Efficacy and ctDNA analysis in an updated cohort of patients with TRK fusion lung cancer treated with larotrectinib
    Meeting Abstract

    Hoejgaard, M.; Drilon, A.; Lin, J. J.; Kummar, S.; Tan, D. S. W.; Patel, J.; Leyvraz, S.; Garcia, V. Moreno; Rosen, L. S.; Solomon, B.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC)
    Meeting Abstract

    Rudin, C. M.; Dowlati, A.; Chen, Y.; Mendivil, A. F. Navarro; Yang, J. C. H.; Stojanovic, G.; Rich, P.; Andric, Z. G.; Wu, Y. L.; Chen, H.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save